Feng Hui, Shi Gaofeng, Xu Qian, Ren Jialiang, Wang Lijia, Cai Xiaojia
Department of Radiology, The Fourth Hospital of Hebei Medical University, No. 12 of Health Road, Shijiazhuang, 050011, China.
GE Healthcare China, Beijing, 100176, China.
Insights Imaging. 2023 Feb 3;14(1):24. doi: 10.1186/s13244-022-01363-9.
The purpose of the study is to investigate the performance of radiomics-based analysis in prediction of pure ground-glass nodule (pGGN) lung adenocarcinomas invasiveness using thin-section computed tomography images.
A total of 382 patients surgically resected single pGGN and pathologically confirmed were enrolled in the retrospective study. The pGGN cases were divided into two groups: the noninvasive group and the invasive adenocarcinoma (IAC) group. 330 patients were randomly assigned to the training and testing cohorts with a ratio of 7:3 (245 noninvasive lesions, 85 IAC lesions), while 52 patients (30 noninvasive lesions, 22 IAC lesions) were assigned to the external validation cohort. A model, radiomics model, and combined clinical-radiographic-radiomic model were built using the LASSO and multivariate backward stepwise regression analysis on the basis of the selected and radiomics features. The area under the curve (AUC) and decision curve analysis (DCA) were used to evaluate and compare the model performance for invasiveness discrimination among the three cohorts.
Three clinical-radiographic features (including age, gender and the mean CT value) and three radiomics features were selected for model building. The combined model and radiomics model performed better than the clinical-radiographic model. The AUCs of the combined model in the training, testing, and validation cohorts were 0.856, 0.859, and 0.765, respectively. The DCA demonstrated the radiomics signatures incorporating clinical-radiographic feature was clinically useful in predicting pGGN invasiveness.
The proposed radiomics-based analysis incorporating the clinical-radiographic feature could accurately predict pGGN invasiveness, providing a noninvasive biomarker for the individualized and precise medical treatment of patients.
本研究旨在利用薄层计算机断层扫描图像,探讨基于影像组学的分析在预测纯磨玻璃结节(pGGN)肺腺癌侵袭性方面的性能。
本回顾性研究共纳入382例接受手术切除且经病理证实为单个pGGN的患者。pGGN病例分为两组:非侵袭性组和浸润性腺癌(IAC)组。330例患者以7:3的比例随机分配至训练组和测试组(245例非侵袭性病变,85例IAC病变),而52例患者(30例非侵袭性病变,22例IAC病变)被分配至外部验证组。基于所选的影像组学特征,使用LASSO和多变量向后逐步回归分析建立了一个模型、影像组学模型和临床-影像学-影像组学联合模型。采用曲线下面积(AUC)和决策曲线分析(DCA)来评估和比较三个队列中模型对侵袭性的鉴别性能。
选择了三个临床-影像学特征(包括年龄、性别和平均CT值)和三个影像组学特征用于模型构建。联合模型和影像组学模型的表现优于临床-影像学模型。联合模型在训练组、测试组和验证组中的AUC分别为0.856、0.859和0.765。DCA表明,纳入临床-影像学特征的影像组学特征在预测pGGN侵袭性方面具有临床实用性。
所提出的结合临床-影像学特征的基于影像组学的分析可以准确预测pGGN的侵袭性,为患者的个体化精准医疗提供一种非侵入性生物标志物。